Perrigo Company plc (PRGO)
NYSE:PRGO

Perrigo Company (PRGO) Stock Price & Analysis

444 Followers

PRGO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$30.29 - $42.56
Previous Close$33.65
Volume180.07K
Average Volume (3M)1.11M
Market Cap
$4.55B
Enterprise Value$8.10B
Total Cash (Recent Filing)$553.00M
Total Debt (Recent Filing)$4.10B
Price to Earnings (P/E)-32.2
Beta0.30
Aug 10, 2023
1.06 (3.17%)
Share Statistics
EPS (TTM)-1.04
Shares Outstanding135,325,847
10 Day Avg. Volume828,302
30 Day Avg. Volume1,114,823
Standard Deviation0.11
R-Squared0.17
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-2.57
Price to Sales (P/S)3.85
Price to Cash Flow (P/CF)58.80
P/FCF Ratio59.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.38
Enterprise Value/Gross Profit5.57
Enterprise Value/Ebitda29.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

PRGO FAQ

What was Perrigo Company plc’s price range in the past 12 months?
Perrigo Company plc lowest stock price was $30.29 and its highest was $42.56 in the past 12 months.
    What is Perrigo Company plc’s market cap?
    Currently, no data Available
    When is Perrigo Company plc’s upcoming earnings report date?
    Perrigo Company plc’s upcoming earnings report date is Aug 10, 2023 which is in 62 days.
      How were Perrigo Company plc’s earnings last quarter?
      Perrigo Company plc released its earnings results on May 09, 2023. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02.
        Is Perrigo Company plc overvalued?
        According to Wall Street analysts Perrigo Company plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Perrigo Company plc pay dividends?
          Perrigo Company plc pays a Quarterly dividend of $0.27 which represents an annual dividend yield of 3.12%. See more information on Perrigo Company plc dividends here
            What is Perrigo Company plc’s EPS estimate?
            Perrigo Company plc’s EPS estimate is $0.52.
              How many shares outstanding does Perrigo Company plc have?
              Perrigo Company plc has 135,325,850 shares outstanding.
                What happened to Perrigo Company plc’s price movement after its last earnings report?
                Perrigo Company plc reported an EPS of $0.45 in its last earnings report, beating expectations of $0.43. Following the earnings report the stock price went down -3.11%.
                  Which hedge fund is a major shareholder of Perrigo Company plc?
                  Among the largest hedge funds holding Perrigo Company plc’s share is Gamco Investors, Inc. ET AL. It holds Perrigo Company plc’s shares valued at 29M.

                    ---

                    Perrigo Company Stock Smart Score

                    The Perrigo Company stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Perrigo Company plc

                    Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals. The Consumer Healthcare Americas segment comprises the U.S., Mexico and Canada consumer healthcare business. The Consumer Healthcare International segment includes branded consumer healthcare business primarily in Europe and consumer focused businesses in the U.K., Australia, and Israel. The Prescription Pharmaceuticals refers to the U.S. prescription pharmaceuticals business. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

                    ---

                    Top 5 ETFs holding PRGO

                    Name
                    Market Value
                    Smart Score
                    Vanguard Dividend Appreciation ETF
                    $28.22M
                    8
                    Vanguard Health Care ETF
                    $17.46M
                    8
                    iShares U.S. Pharmaceuticals ETF
                    $6.59M
                    8
                    iShares Core S&P Total U.S. Stock Market ETF
                    $4.59M
                    8
                    VanEck Pharmaceutical ETF
                    $4.58M
                    8
                    Up to five ETFs with an Outperform Smart Score that hold PRGO. The ETFs are listed according to market value of PRGO within the ETF

                    ---

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Teva Pharmaceutical
                    Mallinckrodt public limited company
                    Amneal Pharmaceuticals
                    Adicet Bio

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis